SHARP-Study - Sorafenib: soon standard therapy with hepatocellular carcinoma?

被引：0
|
作者：
不详
机构：
来源：
ONKOLOGE | 2007年 / 13卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：962 / 962
页数：1
相关论文
共 50 条
  • [1] Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial
    Rimassa, Lorenza
    Santoro, Armando
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 739 - 745
  • [2] Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond
    Gadaleta-Caldarola, Gennaro
    Divella, Rosa
    Mazzocca, Antonio
    Infusino, Stefania
    Ferraro, Emanuela
    Filippelli, Gianfranco
    Daniele, Antonella
    Sabba, Carlo
    Abbate, Ines
    Brandi, Mario
    [J]. FUTURE ONCOLOGY, 2015, 11 (16) : 2263 - 2266
  • [3] PERSONALIZED THERAPY WITH SORAFENIB FOR HEPATOCELLULAR CARCINOMA
    Cabibbo, G.
    Iavarone, M.
    Maida, M.
    Di Martino, A.
    Orlando, E.
    Zavaglia, C.
    Grieco, A.
    Villa, E.
    Piscaglia, F.
    Di Marco, V.
    Colombo, M.
    Craxi, A.
    Camma, C.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S397 - S397
  • [4] Sorafenib, a systemic therapy for hepatocellular carcinoma
    Mendez-Sanchez, Nahum
    Vasquez-Fernandez, Francisco
    Zamora-Valdes, Daniel
    Uribe, Misael
    [J]. ANNALS OF HEPATOLOGY, 2008, 7 (01) : 46 - 51
  • [5] EVALUATION OF TOLERANCE AND OUTCOME OF PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED BY SORAFENIB (AFTER THE SHARP STUDY)
    Ozenne, V.
    Pernot, S.
    Vullierme, M. -P.
    Paradis, V.
    Serste, T.
    Castelnau, C.
    Valla, D.
    Boulet, T.
    Degos, F.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S295 - S295
  • [6] Hepatocellular Carcinoma Cancer Immunotherapy plus Angiogenesis Inhibitors - soon the new Therapy Standard for HCC?
    Vetter, Christine
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (11) : 642 - 642
  • [7] Target Therapy for Hepatocellular Carcinoma: Is Sorafenib for Everybody?
    Daniele, Bruno
    Di Maio, Massimo
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2009, 43 (05) : 389 - 390
  • [8] Systemic therapy for hepatocellular carcinoma: beyond sorafenib
    Boland, Patrick
    Wu, Jennifer
    [J]. CHINESE CLINICAL ONCOLOGY, 2018, 7 (05)
  • [9] Sorafenib and Triptolide as Combination Therapy for Hepatocellular Carcinoma
    Alsaied, Osama
    Sangwan, Veena
    Banerjee, Sulagna
    Chugh, Rohit
    Saluja, Ashok
    Vickers, Selwyn M.
    Jensen, Eric
    [J]. HEPATOLOGY, 2013, 58 : 1073A - 1073A
  • [10] Sorafenib and triptolide as combination therapy for hepatocellular carcinoma
    Alsaied, Osama A.
    Sangwan, Veena
    Banerjee, Sulagna
    Krosch, Tara C.
    Chugh, Rohit
    Saluja, Ashok
    Vickers, Selwyn M.
    Jensen, Eric H.
    [J]. SURGERY, 2014, 156 (02) : 270 - 279
12345